InvenireX is a biotechnology company that offers molecular diagnostics services.
InvenireX has raised $2.6M in total funding. The most recent round was Seed. The last funding was announced in November 2025.
InvenireX's investors include XTX Ventures, Innovate UK, DSW Ventures, Cambridge Technology Capital.
InvenireX is headquartered in Newcastle Upon Tyne, United Kingdom.
InvenireX is a biotechnology company that offers molecular diagnostics services.
InvenireX is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"InvenireX — Funding & Investors." VCBacked, November 18, 2025, https://www.vcbacked.co/company/invenirex. Accessed September 3, 2026.
VCBacked. (2025). InvenireX — Funding & Investors. Retrieved September 3, 2026, from https://www.vcbacked.co/company/invenirex
{{cite web |title=InvenireX — Funding & Investors |url=https://www.vcbacked.co/company/invenirex |website=VCBacked |access-date=September 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated